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Procedural step:
JL 4.0 5F from LCA as contralateral dye injection, from left radial a.
GC: AL1 7F from right femora artery
GW: Wizard 78, Fielder FC, Choice PT extrasupport and extension wire
Procedure:
Wizard 78 wire + Finecross catheter, the wire crossed the lesion and was advanced to
distal PDA with the conﬁrmation of contralateral dye injection. A Mini Trek 1.2 x 12
mm balloon failed to cross the occlusion, dilated before occlusion site at 14 atm. An
Emerge balloon 1.2 x 8 mm failed to cross the lesion either, and the whole system was
pushed out. Re-engaged AL1 and re-advanced GW, it was advanced to PL. An
Emerge 1.2 mm balloon crossed the lesion and dilated the lesions at 10-16 atm. Large
and long dissections were noted from mid-RCA to distal RCA and PL. Re-directed the
GW into PDA with conﬁrmation of contralateral dye injection and changed the wire to
Fielder FC. A 2.5 x 20 mm balllon dilated the occlusion site at 10 atm, but IVUS
failed to crossed the lesion. A 2.25 x 20 mm Trek balloon dilated from proximal PDA
back to mid-RCA at 8 to 16 atm but an Xience Prime stent 2.25 x 23 mm failed to
cross the mid-RCA. We used 6F Guide Liner to improve support but the whole system
was pushed out, re-engaged AL1 and re-inserted GW (Fielder FC) to PDA. An NC
Quantum balloon 3.0 x 20 mm dilated the mid-RCA at 16 atm to get full expansion of
the balloon, IVUS showed the diameter of distal RCA was 2.5-3.0 mm and 3.0-3.5
mm at mid-RCA and 3.5-4.5 mm at proximal RCA, large hematoma was noted at
distal to mid-RCA, 360 degree heavy calciﬁcation of mid-RCA noted. An Xience
Prime stent 2.25 x 13 mm was deployed at proximal PDA to distal RCA at 10 atm and
the balloon dilated RCA at 10-16 atm from distal back to mid-RCA. An Xience Prime
stent 2.75 x 33 failed to cross the mid-RCA and the whole system was pushed out, a
3.0 x 20 mm NC Quantum balloon dilated mid-RCA at 12-16 atm. An Xience Prime
stent 2.75 x 33 mm crossed the lesion and was deployed at distal to mid-RCA with
distal overlapping at 16 atm and the balloon dilated mid-RCA at 16 atm. An Xience
Prime stent 3.0 x 23 mm failed to cross the mid-RCA and the whole system was
pushed out, we re-engaged AL1 and re-inserted Fielder FC wire. We introduced a
Choice PT extrasupport wire to distal RCA as buddy wires and an Xience Prime stent
3.0 x 23 mm crossed the lesion and was deployed at 16 atm with distal overlapping.
An Xience Prime stent 3.5 x 38 mm was inserted and Fielder wire was removed and
the stent was deployed at mid-to proximal RCA at 16 atm with distal overlapping, post
dilated the distal RCA stent with 3.0 x 23 mm balloon at 12 atm and mid-RCA stent at
max 16 atm; Post dilated the mid-to proximal RCA with NC Quantum balloon 4.0 x
20 mm at 16 atm. Type B dissection was noted at very proximal RCA and an Xience
Prime stent 4.0 x 8 mm was deployed at 16 atm. Final angiographic results was
optimal, PL branch has limited ﬂow but it was small with collaterals, therefore, we
stopped the procedure.S138 JACC Vol 63/12/Suppl S j ACase Summary:
A 56-year-old gentleman suffered from intermittent chest tightness. He had risk factor
of hypertension. Physical examination was normal. He received a thallium-201
myocardial perfusion scan that demonstrated inferolateral myocardial ischemia. He
underwent coronary angiography on June 2013 and it showed luminal irregularity of
LAD, septal branches provided collaterals to distal RCA, 80% stenosis of middle LCx
and total occlusion at mid-RCA with collaterals from cornus branch to distal RCA.
PCI with stenting to LCx was performed. On August 2013, the patient was admitted
for RCA PCI. A 7F AL1 guide catheter was inserted through right femoral artery to
engage right coronary ostium and a JL 4.0 5F diagnostic catheter was inserted through
right radial artery to engage left coronary ostium as contralateral contrast injection. A
Wizard 78 guidewire and a ﬁnecross catheter were used, the wire crossed the lesion
and was advanced to PL branch. A 1.2-mm Emerge balloon dilated the occlusion site
causing a large and long dissection from middle RCA to PL branch. The wire was
successfully re-wired to PDA and the guidewire was changed to Fielder FC. IVUS
examined RCA and showed diffuse dissection with large hematoma at middle to distal
RCA and heavy calciﬁcation with dissection at occlusion site. After balloon pre-
dilatation, 5 drug- eluting stents were implanted from PDA back to ostial RCA.
Angiographic result was optimal and IVUS examination showed good stents expan-
sion and apposition.
Conclusion:
Long and large coronary dissection may carry a high risk of mortality and morbidity
during coronary intervention. Avoid forceful contrast injection through guide catheter
following balloon dilatation to the occluded lesion especially when the guide is tightly
engaged. If a large coronary dissection is created, it is important not to perform
contrast angiography until the dissection is secured by the stents implantation.
TCTAP C-114
A Case of Ostial CTO Treated with a "GAIA" Guidewire
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[Clinical Information]
Patient initials or identiﬁer number:
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Procedural step:
Target lesion: Seg.11 (an ostial LCX CTO with acute bend)
Approach: right femoral
Guiding catheters: 7Fr Launcher EBU3.75 (Medtronic)
Microcatheter: Crusade (Kaneka), Corsair (Asahi)
Guidewires: XT-R, Gaia First, SION blue (Asahi)
Balloons: Mini Trek 2.0 mm (Abbott)
Stents: Promus Element 2.25/16 mm, Promus Element 2.25/12 mm (Boston)
IVUS: OptiCross (Boston)
A location of entry of the ostial LCX CTO was conﬁrmed by IVUS examination. Then
operator tried topenetrateproximalcapof theCTOusinganXT-Rguidewire supportedwith
a Cruade double-lumen microcatheter. However, the XT-R was unable to advance into the
CTO because the entry of the CTO had an acute bend. Next, the guidewire was exchanged
for aGaia First guidewire,whichwas able to penetrate proximal cap and advanced tomiddle
of theCTO. Then, after a Corsair microcatheter was delivered along with the guidewire, the
Gaia First was replaced with the XT-R guidewire. Consequently, the XT-R reached distal
true lumen.Afterpredilatation, twoPromusElement stentsweredelivered to the lesionusing
the balloon anchor technique and successfully deployed to the CTO lesion.
Case Summary:
The Gaia guidewre is useful especially for an ostial CTO with an acute bend at entry.JACC Vol 63/12/Suppl S j April 22–25, 2014 j TCTAP Abstracts/CASTCTAP C-115Retrograde Chronic Total Occlusion via Ipsilateral Collaterals
Suma Malini Victor, Anand Gnanaraj
The Madras Medical Mission, India
[Clinical Information]
Patient initials or identiﬁer number:
Mr. S
Relevant clinical history and physical exam:
60 years old male gentleman, known diabetic, normotensive, history of effort dyspnea
and angina class II x 6 months.
Relevant test results prior to catheterization:
ECG: Poor R Wave Progression in anterior leads
ECHO: Severe LV dysfunction
Thallium: Viable myocardium +
Relevant catheterization ﬁndings:
CAG; RCA, LCX free of disease. RCA tortuous
LAD ostial 100% lesion
[Interventional Management]
Procedural step:
procedure done under local anaesthesia through right femoral approach attemptes were
made to cross the lesion antegradely failed lesion was crossed retrogradely from lcx
collateral with ﬁelder xt wire (ﬁelder fc and bmw wires were used to get the 10 x 10
mm otw balloon) lesion was crossed antegradely with cross it 100 xt wire along the
retrograde wire retrograde wire then removed and predilatations were done with 12 x 6
mm trek upto 14 atm for 10 sec and 25 x 15 mm trek upto 14 atm for 10 sec stent
deployment was done to proximal lad using a 275 x 30 mm resolute integrity at 12 atm
for 30 sec saba done with 35 x 8 mm nc voyager upto 18 atm for 10 sec mid lad lesion
was dilated with 25 x 23 mm balloon upto 4 atm for 30 sec check angiogram showed
no residual disease in the proximal lad with dissection at the mid lad with timi iii ﬂow
the procedure was uneventful patient shifted with stable hemodynamicsE/Chronic Total Occlusions S139
